Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
47 studies found for:    Open Studies | "Bronchiectasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Bronchiectasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Natural History of Bronchiectasis
Conditions: Bronchiectasis;   Cystic Fibrosis;   Autoimmune Disease;   Common Variable Immunodeficiency
Intervention:
2 Unknown  Exercise Capacity in Bronchiectasis Resection
Condition: Bronchiectasis
Intervention:
3 Unknown  ELTGOL and Bronchiectasis. Respiratory Therapy
Conditions: Respiratory; Complications, Therapy;   Bronchiectasis
Interventions: Procedure: Low Expiration Open glottis inferolateral (ELTGOL);   Procedure: Stretching
4 Recruiting Prevention of Bronchiectasis in Infants With Cystic Fibrosis
Conditions: Cystic Fibrosis;   Bronchiectasis
Interventions: Drug: Azithromycin;   Drug: Placebo control
5 Recruiting Tayside Rehabilitation in Bronchiectasis Exacerbations (TRIBE) : a Randomized Controlled Trial
Condition: Bronchiectasis
Intervention: Procedure: Pulmonary rehabilitation
6 Unknown  Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis
Conditions: COPD;   Bronchiectasis
Intervention:
7 Unknown  The Effect of Theophylline in the Treatment of Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Theophylline;   Drug: Placebo(for Theophylline)
8 Unknown  The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Formoterol-budesonide;   Drug: Theophylline;   Drug: Placebo
9 Recruiting Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations
Condition: Bronchiectasis
Interventions: Other: Duration;   Drug: Colomycin;   Drug: Meropenem
10 Unknown  Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis
Condition: Bronchiectasis
Interventions: Other: Hypertonic saline;   Other: Isotonic saline
11 Recruiting The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in Adults
Condition: Bronchiectasis
Intervention:
12 Recruiting The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF Bronchiectasis
Condition: Bronchiectasis
Intervention:
13 Unknown  Bacteriology and Inflammation in Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Fluroquinolones;   Drug: Beta-lactamase inhibitor
14 Unknown  A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Conditions: Asthma;   Bronchiectasis
Interventions: Drug: DAS181 dry powder, formulation F02;   Drug: Respitose ML006 (DMV-Fonterra)
15 Recruiting Physical Capacity in Patients With Bronchiectasis Before and After Rehabilitation Program
Condition: Bronchiectasis
Interventions: Other: pulmonary rehabilitation;   Other: conventional program
16 Recruiting Pulmonary Rehabilitation Program (PRP) Versus PRP Plus Nutritional Supplementation in Patients With Bronchiectasis
Condition: Bronchiectasis
Interventions: Other: Pulmonary Rehabilitation;   Dietary Supplement: Hyperproteic oral nutritional supplement enriched with beta-hydroxy-beta-methylbutyrate
17 Unknown  A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Tobramycin;   Drug: Saline
18 Recruiting Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Condition: Bronchiectasis
Interventions: Drug: Ciprofloxacin DPI (BAYQ3939);   Drug: Placebo
19 Recruiting Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Condition: Bronchiectasis
Interventions: Drug: Ciprofloxacin: administered for 28 days on / 28 days off;   Drug: Placebo: administered for 28 days on / 28 days off;   Drug: Ciprofloxacin: administered for 14 days on / 14 days off;   Drug: Placebo: administered for 14 days on / 14 days off
20 Recruiting Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
Conditions: Bronchiectasis;   Lower Respiratory Infection
Intervention: Drug: POL7080

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years